← Eichor
Study identifier: NCT06711952 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)

Condition: Alzheimer Disease · Subjective Cognitive Decline  ·  Sponsor: Ludwig-Maximilians - University of Munich

PhaseNA
Planned participants300
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

The SCD-Q (Subjective Cognitive Decline-Questionnaire) is an established instrument to quantify self-perceived cognitive decline. Both self- and informant-rated versions of the SCD-Q are available. However, the SCD-Q has not been validated in the German language yet. Hence, the investigators aim to validate the self-reported SCD-Q in a clinical sample in Germany.

This description comes directly from the study's public registry record.

Talk to the study team

Carolin Kurz, Dr.  ·  +4989440055863  ·  Psy.Alzheimerzentrum@med.uni-muenchen.de

Always discuss trial participation with your own doctor first.

Locations (1)

Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU KlinikumsMünchen, Bavaria, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06711952